Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Summary

in vivo-jetRNA®+ is a ready to use lipid-based transfection reagent specifically developed for mRNA therapeutics to address current limit of LNPs in targeting different organs and cell types.

In this webinar Dr. Malik Hellal and Dr. Claire Guéguen present Polyplus’ latest innovation for mRNA therapeutics. in vivo-jetRNA®+ is a ready to use lipid-based transfection reagent specifically developed to address current limit of LNPs in targeting different organs and cell types while maintaining 100% of mRNA encapsulation, stability of liposome size at high mRNA concentration and simplicity of use and preparation (no formulation equipment is required).

Learn more

Resources

Pressroom

Polyplus Builds on Research and Commercial mRNA Support Portfolio with in vivo-jetRNA®+ Transfection Reagent

View All Resources